Diisobutylaluminum hydride → HCID 58456327, compound
Reaction equation
[CH:1]1([C:4]2[C:9]([F:10])=[CH:8][N:7]=[C:6]([NH:11][C:12]3[CH:13]=[C:14]([C:19]4[S:23][C:22]([C:24]([OH:34])([C:30]([F:33])([F:32])[F:31])[C:25](OCC)=[O:26])=[N:21][CH:20]=4)[CH:15]=[C:16]([CH3:18])[CH:17]=3)[N:5]=2)[CH2:3][CH2:2]1.CC(C[AlH]CC(C)C)C>O1CCCC1>[CH:1]1([C:4]2[C:9]([F:10])=[CH:8][N:7]=[C:6]([NH:11][C:12]3[CH:13]=[C:14]([C:19]4[S:23][C:22]([C:24]([OH:34])([C:30]([F:33])([F:32])[F:31])[CH2:25][OH:26])=[N:21][CH:20]=4)[CH:15]=[C:16]([CH3:18])[CH:17]=3)[N:5]=2)[CH2:2][CH2:3]1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 0 °C
Procedure
To a solution of ethyl 2-(5-{3-[(4-cyclopropyl-5-fluoropyrimidin-2-yl)amino]-5-methylphenyl}-1,3-thiazol-2-yl)-3,3,3-trifluoro-2-hydroxypropanoate (36 mg, 0.073 mmol) in tetrahydrofuran (10 mL) at −78° C. was added DIBAL-H (0.160 mL 0.160 mmol). After 30 minutes, the reaction mixture was warmed to 0° C. After 2 hours, the reaction mixture was quenched with saturated ammonium chloride solution, then diluted with ethyl acetate, washed with brine, dried over magnesium sulfate, filtered, and concentrated. The residue was purified by preparative HPLC Reverse phase (C-18), eluting with acetonitrile/water+0.05% TFA to give 2-(5-{3-[(4-cyclopropyl-5-fluoropyrimidin-2-yl)amino]-5-methylphenyl}-1,3-thiazol-2-yl)-3,3,3-trifluoropropane-1,2-diol (3.5 mg, 0.001 mmol, 10%). MS ESI: [M+H]+ m/z 455.1. 1H NMR (500 MHz, DMSO-d6) δ 9.58 (bs, 1H); 8.38 (m, 1H); 8.06 (s, 1H); 7.89 (s, 1H); 7.43 (s, 1H); 7.07 (s, 1H); 3.99 (s, 2H); 2.29 (s, 3H); 2.28-2.23 (m, 1H); 1.18-1.14 (m, 4H). rhSYK activity=+++
Workup
- waitAfter 2 hours
- customthe reaction mixture was quenched with saturated ammonium chloride solution
- additiondiluted with ethyl acetate
- washwashed with brine
- dry with materialdried over magnesium sulfate
- filtrationfiltered
- concentrationconcentrated
- customThe residue was purified by preparative HPLC Reverse phase (C-18)
- washeluting with acetonitrile/water+0.05% TFA
Sources & evidence
- ORD record
- ord-9fd9d48040544117a126567fde99e478
- Source dataset
- uspto-grants-2014_06
- Patent number
- US08759366B2
Reaction notes
Loading…